Press Releases

DaVita Inc. today announced its annual cycling event, Tour DaVita, raised nearly $1 million to benefit Bridge of Life, a nonprofit founded by DaVita that is focused on strengthening health care...

DaVita Kidney Care, a leading provider of kidney care services in the United States, issued the following statement: "We are grateful that Californians voted down Proposition 23, a harmful ballot...

DaVita Inc. (NYSE: DVA) announced financial and operating results for the third quarter ended September 30, 2020. During the quarter, notwithstanding the challenges of responding to COVID-19, the...

DaVita Clinical Research (DCR) will present 14 research abstracts from company representatives and medical professionals at the American Society of Nephrology (ASN) annual Kidney Week occurring...

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Thursday, October 29, 2020, at 5:00 p.m. Eastern Time. The company...

DaVita joins Dialysis Patient Citizens in supporting BETTER Kidney Care Act Bipartisan, bicameral legislation would improve quality of life for patients with kidney disease DaVita joins...

DAVITA INC. (NYSE: DVA) ("DaVita") a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care...

DAVITA INC. (NYSE: DVA) ("DaVita"), a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care...

DaVita Inc. announced today that its Board of Directors appointed a new independent director, Mr. Shawn Guertin, to join the Board, effective Sept. 15. Mr. Guertin joins the Board with nearly 35...

In response to Hurricane Laura, DaVita Kidney Care has opened its dialysis centers in Texas, Louisiana, Alabama and Mississippi to anyone who needs treatment, regardless of where those patients...

DaVita Clinical Research (DCR), a subsidiary of DaVita Inc., has begun enrollment on two clinical research trials to study how COVID-19 affects people with end stage kidney disease (ESKD) who are...

DaVita Inc. (NYSE: DVA) ("DaVita"), a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care...

DaVita has expanded a tuition and support program for its clinical teammates to help them earn an associate's degree in nursing. The program, named Bridge to Your Dreams, includes comprehensive...

DaVita Inc. (NYSE: DVA) announced today that its Board of Directors appointed a new independent director, Ms. Paula A. Price, to join the Board, effective September 1, 2020. "We are very excited...

DaVita Inc. (NYSE: DVA) ("DaVita") announced today the pricing of its previously announced private offering of $1.5 billion aggregate principal amount of senior notes due 2031 (the "2031 notes")....

DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private offering of $1.5 billion aggregate principal amount of senior notes due 2031 (the "2031 notes"), subject to...

During the second quarter of 2020, DaVita (NYSE: DVA) remained focused on its top priorities, the safety and care of its patients, caregivers, teammates and physician partners. In the face of the...

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Thursday, July 30, 2020, at 5:00 p.m. Eastern Time. The company plans...

DaVita Kidney Care recently announced Mandy Hale as the company's chief nursing officer. Hale most recently served as the company's vice president of nursing, overseeing more than 18,000 nurses...

Nephrology Practice Solutions (NPS) today announced that Dr. Thao Truong Pascual has assumed the role of chief medical officer (CMO). As a subsidiary of DaVita, NPS owns or manages nephrology...

DaVita Inc. (NYSE: DVA) ("DaVita") announced today the pricing of its previously announced private offering of $1.75 billion aggregate principal amount of senior notes due 2030 (the "2030 notes")....

DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private offering of $1.75 billion aggregate principal amount of senior notes due 2030 (the "2030 notes"), subject to...

DaVita Kidney Care recently announced its continued support for U.S. employees, known as teammates, during the COVID-19 pandemic by implementing and strengthening programs specifically created to...

During the first quarter of 2020, DaVita Inc. (NYSE: DVA) took significant steps to respond to the novel coronavirus (COVID-19) pandemic while continuing to provide high-quality care for its...

As part of its continued efforts to further transform patient care, DaVita today unveiled DaVita Venture Group (DVG). This group plans to accelerate DaVita's efforts to develop and deploy...